fructose-1,6-diphosphate has been researched along with Angor Pectoris in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Bari, M; Fattirolli, F; Ferrucci, L; Marchionni, N; Moschi, G; Paoletti, M; Salani, B | 1 |
Amatuni, GV; Badalian, GO; Episkoposian, NG | 1 |
1 trial(s) available for fructose-1,6-diphosphate and Angor Pectoris
Article | Year |
---|---|
Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Exercise; Female; Fructosediphosphates; Heart Rate; Hemodynamics; Hexosediphosphates; Humans; Injections, Intravenous; Male; Middle Aged | 1988 |
1 other study(ies) available for fructose-1,6-diphosphate and Angor Pectoris
Article | Year |
---|---|
[Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
Topics: Adult; Aged; Alcian Blue; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Aggregation; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged; Myocardial Infarction; Pentoxifylline; Theobromine | 1987 |